Meeting
2023 ASCO Breakthrough
Clinical validation of a ctDNA-based assay for multi-cancer detection: An interim report from a Vietnamese longitudinal prospective cohort study of 2795 participants.
Authors
Hanh Thi-Hue Nguyen
Medical Genetics Institute, Ho Chi Minh City, Viet Nam
Hanh Thi-Hue Nguyen , Le Son Tran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Gastrointestinal Cancer,Gynecologic Cancer,Head and Neck Cancer,Quality of Care,Genetics/Genomics/Multiomics,Healthcare Equity and Access to Care,Healthtech Innovations,Models of Care and Care Delivery,Population Health,Viral-Mediated Malignancies
Sub Track
Early Detection and Surveillance
Clinical Trial Registration Number
NCT05227261
Citation
JCO Global Oncology 9, 2023 (suppl 1; abstr 135)
DOI
10.1200/GO.2023.9.Supplement_1.135
Abstract #
135
Poster Bd #
H10
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
A multi-center study for colorectal cancer early detection among patients with high-risk disease using a cell-free fragmentomics assay.
First Author: Jierong Chen
Poster
2024 ASCO Annual Meeting
Budget impact model of LungFlag, a predictive risk model for lung cancer screening.
First Author: Michael K. Gould
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prospective study of a multi-modal blood-based test for colorectal cancer screening.
First Author: Paloma Peinado
Poster
2023 ASCO Quality Care Symposium
Analysing the colorectal cancer screening patterns during the COVID-19 pandemic and their effects on patient outcomes.
First Author: Joshua Ling